|
|
Office Locations:
|
221 Geneseo Rd.
San Antonio, TX 78209
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Feik Enterprises was founded by John W. Feik, who served as President and Chief Operating Officer of DFB Pharmaceuticals, Inc., where he was involved with HealthPoint Biotherapeutics, Phyton Biotech, and StemBioSys, Inc., among other companies. He is also a philanthropist and founded the Feik School of Pharmacy at the University of the Incarnate Word. Mr. Feik has been a director of ExThera Medical Corporation since September 2014 and is a also a director of BioBridge Global and the Texas Research & Technology Foundation. In addition to his directorial roles, Mr. Feik serves as Trustee at Texas Biomedical Research Institute (formerly the Southwest Foundation for Biomedical Research). Real estate investments include several San Antonio-area shopping centers and hotels, including the Wyndham Garden locations near UTSA and along the River Walk.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
